Page last updated: 2024-08-23

paclitaxel and Esophagitis

paclitaxel has been researched along with Esophagitis in 53 studies

Research

Studies (53)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	18 (33.96)	18.2507
2000's	18 (33.96)	29.6817
2010's	15 (28.30)	24.3611
2020's	2 (3.77)	2.80

Authors

Authors	Studies
Chen, T; Chen, Y; Chen, Z; Cheng, N; Hu, Y; Hu, Z; Liu, D; Liu, Y; Wang, C; Wang, Z; Xu, Y; Yan, G; Yao, S; Zhang, T; Zhao, G	1
Fujimoto, A; Ichinose, Y; Matsuura, K; Nukui, A; Osaki, A; Saeki, T	1
Cheng, Y; Cui, W; Hu, C; Li, B; Yang, H; Zhu, Y	1
Batus, M; Bonomi, P; Dandekar, VK; Fidler, MJ; Kiel, K; Sher, DJ; Young, J	1
Chen, J; Chen, M; Li, J; Lin, Y; Liu, J; Pan, C; Pan, J; Zhu, K	1
Bai, Y; Chen, M; Hu, Y; Li, H; Li, J; Li, Q; Li, T; Lu, B; Lu, Y; Ma, Z; Ouyang, W; Su, S; Wang, X; Wang, Y	1
Algara, M; Fernández-Velilla, E; Foro, P; Lacruz, M; López, JL; Lozano, J; Membrive, I; Quera, J; Reig, A; Rodríguez, N; Sanz, X	1
Berkovic, K; Eberhardt, WE; Gauler, T; Jawad, JA; Korfee, S; Krbek, T; Pöttgen, C; Stamatis, G; Stuschke, M; Teschler, H	1
Honova, H; Kralova, D; Pazdro, A; Pazdrova, G; Petruzelka, L; Smejkal, M; Zemanova, M	1
Bradley, JD; Byhardt, R; Choy, H; Fowler, J; Gore, E; Govindan, R; Graham, MV; Michalski, JM; Moughan, J; Purdy, JA	1
Balboni, TA; Haddad, RI; Norris, CM; Posner, MR; Schoenfeld, JD; Sher, DJ; Tishler, RB	1
Allen, PK; Chang, JY; Cox, JD; Gillin, M; Komaki, R; Liao, Z; Lu, C; Sejpal, S; Tsao, A; Wei, X	1
Battafarano, R; Birnbaum, A; Burrows, W; Dipetrillo, T; Fontaine, J; Horiba, N; Ng, T; Oldenburg, N; Perez, K; Safran, H; Suntharalingam, M	1
Jeremić, B; Miličić, B; Milisavljevic, S	1
Chiba, Y; Fukuda, H; Fukuoka, M; Kokubo, M; Kudoh, S; Nakagawa, K; Nakanishi, Y; Negoro, S; Nishimura, Y; Tada, T; Tsujino, K	1
Bi, N; Cao, J; Li, J; Li, W; Liang, J; Lv, J; Ou, G; Ren, H; Wang, L; Wu, S; Zhang, X; Zhou, Z	1
Deschesne, K; Fraser, R; Halle, JS; Johnson, H; Moore, DT; Morris, DE; Rosenman, JG; Socinski, MA	1
Senzer, N	1
Ang, P; Ang, PT; Chew, L; Fong, KW; Foo, KF; Lee, KM; Leong, SS; Lim, SH; Ong, YK; Tai, BC; Tan, EH; Wee, J; Wilder-Smith, E	1
Ball, DL; MacManus, M; Michael, M; Millward, M; Muceniekas, L; O'Kane, C; Richardson, G; Rischin, D; Ryan, G; Smith, JG; Solomon, B; Wirth, A	1
Antonadou, D; Bolanos, N; Petridis, A; Sagriotis, A; Synodinou, M; Throuvalas, N	1
Antonadou, D; Bolanos, N; Petridis, A; Sagriotis, A; Synodinou, M; Throuvalas, N; Veslemes, M	1
Ang, P; Fong, KW; Foo, KF; Lee, KM; Leong, SS; Ong, YK; Tan, EH; Wee, J	1
Axelrod, R; Byhardt, R; Komaki, R; Langer, C; Machtay, M; Movsas, B; Nicolaou, N; Sarna, L; Scott, C; Smith, C; Wasserman, T; Werner-Wasik, M	1
Harman, EM; Keene, KS; Knauf, DG; McCarley, D; Zlotecki, RA	1
Abadie-Lacourtoisie, S; Capitain, O; Lortholary, A	1
Bao, Y; Chen, M; Cui, NJ; Deng, XW; Li, KX; Lu, TX; Wang, WH; Xu, GC; Zhang, L	1
Akerman, P; Dipetrillo, T; Doyle, LA; Evans, D; Kennedy, N; Kennedy, T; Krasna, M; Ng, T; Plette, A; Safran, H; Spector, J; Suntharalingam, M; Wanebo, H	1
Wu, SX; Xie, CY; Zhang, P	1
Browne, MJ; Choy, H	1
Alberts, M; Antonia, SJ; Hilstro, J; Hubbell, D; Robinson, L; Ruckdeschel, JC; Wagner, H; Williams, C	1
Choy, H; Safran, H	1
Greco, FA; Hainsworth, JD; Stroup, SL	1
Akerley, W; Choy, H; Clark, J; Glantz, M; Leone, L; Papa, A; Puthawala, Y; Rege, V; Safran, H; Soderberg, C	1
Choy, H; Cole, BF; Yee, L	1
Greco, FA; Hainsworth, JD	1
Faoro, C; Goerg, C; Havemann, K; Kettner, H; Pfab, R; Wolf, M	1
Aisner, J; Bahri, S; Belani, CP; Capazolli, MJ; Day, R; Engstrom, C; Hiponia, D; Jett, J	1
Akerley, W; Choy, H; Chung, C; Graziano, S; Safran, H	1
Emiliani, E; Giannini, M; Marangolo, M; Rosti, G; Vertogen, B; Zumaglini, F	1
Casaretti, R; Comella, G; Comella, P; Daponte, A; Fiore, F; Frasci, G; Gravina, A; Guida, C; Parziale, A; Scoppa, G	1
Carey, RW; Choi, NC; Grillo, HC; Grossbard, ML; Lynch, TJ; Mathisen, DJ; Moncure, AC; Wain, JC; Wright, CD	1
Golomb, HM; Haraf, DJ; Hoffman, PC; Masters, GA; Mauer, AM; Vokes, EE; Watson, SM	1
Akerley, W; Choy, H; Chung, C; Cole, B; Graziano, S; Kennedy, T; Safran, H; Williams, T	1
Grinblatt, DL; Malloy, R; Williams, SF; Zimmerman, TM	1
Choy, H; Knill-Selby, E; LaPorte, K; Mohr, P; Shyr, Y	1
Bahlitzanakis, N; Beroukas, K; Christodoulou, M; Froudarakis, M; Georgoulias, V; Giatromanolaki, A; Kostantelos, J; Koukourakis, MI; Koumiotaki, S; Kyrias, G; Skarlatos, J	1
Akerman, P; Chen, MH; Gaissert, H; Graziano, S; Hesketh, PJ; Koness, J; Moore, T; Safran, H; Wanebo, HJ	1
Borgmeier, A; Flentje, M; Huber, RM; Kirschner, J; Lang, S; Schmidt, M; Willner, J	1
Abe, M; Endo, M; Hirota, S; Hishikawa, Y; Kado, T; Kono, M; Kotani, Y; Obayashi, K; Satouchi, M; Takada, Y; Tsujino, K	1
Axelrod, RS; Chapman, AE; Curran, WJ; Deshields, M; Friedland, DP; Grubbs, S; Hauck, W; Rose, LJ; Werner-Wasik, M	1

Reviews

2 review(s) available for paclitaxel and Esophagitis

Article	Year
Combined-modality therapy for advanced non-small cell lung cancer: paclitaxel and thoracic irradiation. Seminars in oncology, 1995, Volume: 22, Issue:6 Suppl 15 Topics: Ambulatory Care; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Hypersensitivity; Esophagitis; Follow-Up Studies; Humans; Infusions, Intravenous; Lung Neoplasms; Neutropenia; Paclitaxel; Premedication; Radiation Pneumonitis; Radiation-Sensitizing Agents; Radiotherapy Dosage; Radiotherapy, High-Energy; Remission Induction	1995
Sequential chemo- and radiochemotherapy with weekly paclitaxel (Taxol) and 3D-conformal radiotherapy of stage III inoperable non-small cell lung cancer. Results of a dose escalation study. Lung cancer (Amsterdam, Netherlands), 2001, Volume: 32, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cohort Studies; Combined Modality Therapy; Disease-Free Survival; Drug Hypersensitivity; Esophagitis; Humans; Leukopenia; Life Tables; Lung Neoplasms; Maximum Tolerated Dose; Nausea; Neoplasm Staging; Paclitaxel; Prospective Studies; Radiation Injuries; Radiation Pneumonitis; Radiotherapy, Conformal; Remission Induction; Survival Analysis; Survival Rate; Treatment Outcome; Vomiting	2001

Article

Year

Combined-modality therapy for advanced non-small cell lung cancer: paclitaxel and thoracic irradiation.

Seminars in oncology, 1995, Volume: 22, Issue:6 Suppl 15

Topics: Ambulatory Care; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Hypersensitivity; Esophagitis; Follow-Up Studies; Humans; Infusions, Intravenous; Lung Neoplasms; Neutropenia; Paclitaxel; Premedication; Radiation Pneumonitis; Radiation-Sensitizing Agents; Radiotherapy Dosage; Radiotherapy, High-Energy; Remission Induction

1995

Sequential chemo- and radiochemotherapy with weekly paclitaxel (Taxol) and 3D-conformal radiotherapy of stage III inoperable non-small cell lung cancer. Results of a dose escalation study.

Lung cancer (Amsterdam, Netherlands), 2001, Volume: 32, Issue:2

Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cohort Studies; Combined Modality Therapy; Disease-Free Survival; Drug Hypersensitivity; Esophagitis; Humans; Leukopenia; Life Tables; Lung Neoplasms; Maximum Tolerated Dose; Nausea; Neoplasm Staging; Paclitaxel; Prospective Studies; Radiation Injuries; Radiation Pneumonitis; Radiotherapy, Conformal; Remission Induction; Survival Analysis; Survival Rate; Treatment Outcome; Vomiting

2001

Trials

41 trial(s) available for paclitaxel and Esophagitis

Article	Year
Phase I Trial of Intensity-Modulated Hyperfractionated Radiotherapy Boost with Concurrent Chemotherapy Immediately Following Standard Chemoradiotherapy in Patients Primarily with Advanced Intra-thoracic/Cervical Esophageal Squamous Cell Carcinomas. International journal of radiation oncology, biology, physics, 2020, 02-01, Volume: 106, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Chemoradiotherapy; Dose Fractionation, Radiation; Esophageal Fistula; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagitis; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Paclitaxel; Radiation Pneumonitis; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Re-Irradiation; Tumor Burden	2020
PL03.05 An intergroup randomized phase III comparison of standard-dose (60 Gy) vs high-dose (74 Gy) chemoradiotherapy (CRT) +/- cetuximab (cetux) for stage III non-small cell lung cancer (NSCLC): results on cetux from RTOG 0617. Clinical advances in hematology & oncology : H&O, 2014, Volume: 12, Issue:1 Suppl 1 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cetuximab; Chemoradiotherapy; Consolidation Chemotherapy; Disease-Free Survival; ErbB Receptors; Esophagitis; Female; Humans; Lung Neoplasms; Male; Neoplasm Proteins; Paclitaxel; Protein Kinase Inhibitors; Radiation Injuries; Radiotherapy Dosage; Survival Analysis	2014
O02.03 Value of adding erlotinib to thoracic radiation therapy with chemotherapy for stage III non-small cell lung cancer: a prospective phase II study. Clinical advances in hematology & oncology : H&O, 2014, Volume: 12, Issue:1 Suppl 1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Consolidation Chemotherapy; Disease-Free Survival; DNA Mutational Analysis; DNA, Neoplasm; Docetaxel; Erlotinib Hydrochloride; Esophagitis; Genes, erbB-1; Humans; Lung Neoplasms; Paclitaxel; Prospective Studies; Quinazolines; Radiation Injuries; Radiation Pneumonitis; Radiation-Sensitizing Agents; Radiotherapy Dosage; Survival Analysis; Taxoids	2014
Three-Dimensional Radiation Therapy to the Primary Tumor With Concurrent Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer: Results of a Multicenter Phase 2 Study From PPRA-RTOG, China. International journal of radiation oncology, biology, physics, 2015, Nov-15, Volume: 93, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; China; Cisplatin; Confidence Intervals; Disease-Free Survival; Docetaxel; Esophagitis; Female; Humans; Karnofsky Performance Status; Leukopenia; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Paclitaxel; Pemetrexed; Prospective Studies; Radiation Pneumonitis; Radiotherapy; Survival Rate; Taxoids; Thrombocytopenia; Treatment Outcome; Vinblastine; Vinorelbine; Young Adult	2015
Intensified high-dose chemoradiotherapy with induction chemotherapy in patients with locally advanced non-small-cell lung cancer-safety and toxicity results within a prospective trial. International journal of radiation oncology, biology, physics, 2010, Mar-01, Volume: 76, Issue:3 Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Esophagitis; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Pneumonia; Prospective Studies; Remission Induction; Survival Analysis; Vinblastine; Vinorelbine	2010
Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2010, Volume: 23, Issue:2 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Dose Fractionation, Radiation; Esophageal Neoplasms; Esophagitis; Female; Fluorouracil; Follow-Up Studies; Humans; Leukopenia; Longitudinal Studies; Male; Middle Aged; Neoadjuvant Therapy; Neutropenia; Paclitaxel; Prospective Studies; Radiotherapy, Adjuvant; Remission Induction; Survival Rate; Thrombocytopenia; Treatment Outcome	2010
A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117. International journal of radiation oncology, biology, physics, 2010, Jun-01, Volume: 77, Issue:2 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Non-Small-Cell Lung; Clinical Protocols; Combined Modality Therapy; Dose Fractionation, Radiation; Esophagitis; Female; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Paclitaxel; Radiation Pneumonitis; Radiotherapy, Conformal	2010
Neoadjuvant paclitaxel poliglumex, cisplatin, and radiation for esophageal cancer: a phase 2 trial. American journal of clinical oncology, 2012, Volume: 35, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Dose Fractionation, Radiation; Drug Administration Schedule; Esophageal Neoplasms; Esophagectomy; Esophagitis; Esophagogastric Junction; Fatigue; Female; Humans; Male; Middle Aged; Nausea; Neoadjuvant Therapy; Paclitaxel; Polyglutamic Acid; Treatment Outcome	2012
Concurrent hyperfractionated radiation therapy and chemotherapy in locally advanced (Stage III) non-small-cell lung cancer: single institution experience with 600 patients. International journal of radiation oncology, biology, physics, 2012, Mar-01, Volume: 82, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Disease-Free Survival; Dose Fractionation, Radiation; Drug Administration Schedule; Esophagitis; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Pneumonia; Retrospective Studies; Treatment Outcome	2012
A Phase I study of chemoradiotherapy with use of involved-field conformal radiotherapy and accelerated hyperfractionation for Stage III non-small cell lung cancer: WJTOG 3305. International journal of radiation oncology, biology, physics, 2012, May-01, Volume: 83, Issue:1 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemoradiotherapy; Dose Fractionation, Radiation; Drug Administration Schedule; Esophagitis; Female; Fever; Humans; Injections, Intravenous; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Paclitaxel; Radiotherapy, Conformal; Tumor Burden	2012
Randomized phase II study of concurrent cisplatin/etoposide or paclitaxel/carboplatin and thoracic radiotherapy in patients with stage III non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 2012, Volume: 77, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Esophagitis; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Neutropenia; Paclitaxel; Radiation Pneumonitis; Treatment Outcome	2012
High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial. International journal of radiation oncology, biology, physics, 2002, Oct-01, Volume: 54, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Esophagitis; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Prognosis; Radiation Injuries; Radiotherapy Dosage; Remission Induction; Survival Analysis; Treatment Failure	2002
A phase III randomized evaluation of amifostine in stage IIIA/IIIB non-small cell lung cancer patients receiving concurrent carboplatin, paclitaxel, and radiation therapy followed by gemcitabine and cisplatin intensification: preliminary findings. Seminars in oncology, 2002, Volume: 29, Issue:6 Suppl 19 Topics: Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Cytoprotection; Deoxycytidine; Esophagitis; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Prospective Studies; Radiation Injuries; Radiation-Protective Agents	2002
Randomized double-blind trial of combined modality treatment with or without amifostine in unresectable stage III non-small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, May-01, Volume: 21, Issue:9 Topics: Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Double-Blind Method; Esophagitis; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Placebos; Radiation Injuries; Radiation-Protective Agents; Treatment Outcome	2003
Phase I/II study of concurrent twice-weekly paclitaxel and weekly cisplatin with radiation therapy for stage III non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 2003, Volume: 41, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Esophagitis; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Survival Analysis; Treatment Outcome	2003
Effect of amifostine on toxicities associated with radiochemotherapy in patients with locally advanced non-small-cell lung cancer. International journal of radiation oncology, biology, physics, 2003, Oct-01, Volume: 57, Issue:2 Topics: Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Esophagitis; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mouth Mucosa; Paclitaxel; Radiation Injuries; Radiation Pneumonitis; Radiation-Protective Agents; Radiotherapy Dosage; Stomatitis; Treatment Outcome	2003
Amifostine reduces radiochemotherapy-induced toxicities in patients with locally advanced non-small cell lung cancer. Seminars in oncology, 2003, Volume: 30, Issue:6 Suppl 18 Topics: Aged; Amifostine; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Esophagitis; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Radiation Injuries; Radiation Pneumonitis; Radiation-Protective Agents; Radiation-Sensitizing Agents	2003
Chemo-radiotherapy for stage III unresectable non-small cell lung cancer long-term results of a prospective study. Respiratory medicine, 2004, Volume: 98, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Disease-Free Survival; Esophagitis; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Prospective Studies; Survival Rate; Treatment Outcome	2004
Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Apr-01, Volume: 23, Issue:10 Topics: Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Deglutition Disorders; Dose Fractionation, Radiation; Esophagitis; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Quality of Life; Radiation Injuries; Radiation-Protective Agents; Survival Analysis; Treatment Outcome	2005
Five-year results of a phase II trial of hyperfractionated radiotherapy and concurrent daily cisplatin chemotherapy for stage III non-small-cell lung cancer. American journal of clinical oncology, 2005, Volume: 28, Issue:3 Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Esophagitis; Female; Follow-Up Studies; Humans; Life Tables; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Paclitaxel; Radiation Injuries; Radiation Pneumonitis; Radiation-Sensitizing Agents; Radiotherapy, High-Energy; Survival Analysis; Survival Rate; Treatment Outcome	2005
Cetuximab with concurrent chemoradiation for esophagogastric cancer: assessment of toxicity. International journal of radiation oncology, biology, physics, 2008, Feb-01, Volume: 70, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Drug Hypersensitivity; Esophageal Neoplasms; Esophagitis; Facial Dermatoses; Feasibility Studies; Female; Humans; Male; Middle Aged; Paclitaxel; Stomach Neoplasms	2008
Paclitaxel as a radiation sensitizer in non-small cell lung cancer. Seminars in oncology, 1995, Volume: 22, Issue:3 Suppl 6 Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Esophagitis; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Radiation-Sensitizing Agents	1995
Concurrent paclitaxel/cisplatin with thoracic radiation in patients with stage IIIA/B non-small cell carcinoma of the lung. Seminars in oncology, 1995, Volume: 22, Issue:4 Suppl 9 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Esophagitis; Feasibility Studies; Female; Humans; Infusions, Intravenous; Lung; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Paclitaxel; Radiotherapy; Radiotherapy Dosage; Remission Induction; Thorax	1995
Preliminary analysis of a phase II study of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer. Seminars in oncology, 1995, Volume: 22, Issue:4 Suppl 9 Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drug Administration Schedule; Drug Tolerance; Esophagitis; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Neutropenia; Paclitaxel; Radiotherapy; Radiotherapy Dosage; Remission Induction	1995
Paclitaxel by 1-hour infusion in combination chemotherapy of stage III non-small cell lung cancer. Seminars in oncology, 1995, Volume: 22, Issue:4 Suppl 9 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Esophagitis; Etoposide; Follow-Up Studies; Humans; Infusions, Intravenous; Injections, Intravenous; Leukopenia; Lung Neoplasms; Neoplasm Staging; Neutropenia; Paclitaxel; Radiotherapy; Remission Induction	1995
Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Hypersensitivity; Esophagitis; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Paclitaxel; Radiotherapy Dosage	1994
Combined-modality therapy for advanced non-small cell lung cancer: paclitaxel and thoracic irradiation. Seminars in oncology, 1995, Volume: 22, Issue:6 Suppl 15 Topics: Ambulatory Care; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Hypersensitivity; Esophagitis; Follow-Up Studies; Humans; Infusions, Intravenous; Lung Neoplasms; Neutropenia; Paclitaxel; Premedication; Radiation Pneumonitis; Radiation-Sensitizing Agents; Radiotherapy Dosage; Radiotherapy, High-Energy; Remission Induction	1995
One-hour paclitaxel in the treatment of non-small cell lung cancer. Seminars in oncology, 1996, Volume: 23, Issue:6 Suppl 16 Topics: Adolescent; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Drug Tolerance; Esophagitis; Humans; Infusions, Parenteral; Lung Neoplasms; Male; Paclitaxel; Peripheral Nervous System Diseases; Survival Rate	1996
Chemoradiotherapy in non-small cell lung cancer: paclitaxel/carboplatin/radiotherapy in regionally advanced disease. Seminars in oncology, 1996, Volume: 23, Issue:6 Suppl 16 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drug Administration Schedule; Esophagitis; Humans; Lung Neoplasms; Middle Aged; Mucous Membrane; Neutropenia; Paclitaxel; Radiation-Sensitizing Agents; Survival Rate	1996
Paclitaxel plus carboplatin and concurrent radiation therapy for patients with locally advanced non-small cell lung cancer. Seminars in oncology, 1996, Volume: 23, Issue:6 Suppl 16 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drug Administration Schedule; Esophagitis; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Pneumonia; Radiation-Sensitizing Agents; Radiotherapy Dosage; Treatment Outcome	1996
Phase I/II study of paclitaxel and radiotherapy in non-small cell lung cancer. Seminars in oncology, 1996, Volume: 23, Issue:6 Suppl 16 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Drug Tolerance; Esophagitis; Female; Humans; Infusions, Intravenous; Leukopenia; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Peripheral Nervous System Diseases; Radiation-Sensitizing Agents; Radiotherapy; Radiotherapy Dosage	1996
Weekly paclitaxel and cisplatin with concurrent radiotherapy in locally advanced non-small-cell lung cancer: a phase I study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:4 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Esophagitis; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Paclitaxel; Radiotherapy Dosage; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome	1997
Induction therapy for esophageal cancer with paclitaxel and hyperfractionated radiotherapy: a phase I and II study. The Journal of thoracic and cardiovascular surgery, 1997, Volume: 114, Issue:5 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Dose Fractionation, Radiation; Esophageal Neoplasms; Esophagitis; Female; Fluorouracil; Humans; Male; Middle Aged; Paclitaxel; Survival Rate	1997
Phase I study of docetaxel with concomitant thoracic radiation therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:1 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Esophageal Neoplasms; Esophagitis; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Radiotherapy Dosage; Taxoids; Treatment Outcome	1998
Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Disease-Free Survival; Esophagitis; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Radiation-Sensitizing Agents; Treatment Failure	1998
A Phase I dose escalation trial of continuous infusion paclitaxel to augment high dose cyclophosphamide and thiotepa plus stem cell rescue for the treatment of patients with advanced breast carcinoma. Cancer, 1998, Oct-15, Volume: 83, Issue:8 Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Breast Neoplasms; Carcinoma; Cohort Studies; Cyclophosphamide; Diarrhea; Esophagitis; Female; Hematopoietic Stem Cell Transplantation; Hemorrhage; Humans; Incidence; Infusions, Intravenous; Lung Diseases; Middle Aged; Neoplasm Staging; Paclitaxel; Pulmonary Alveoli; Remission Induction; Stomatitis; Survival Rate; Thiotepa; Transplantation, Autologous	1998
Esophagitis in combined modality therapy for locally advanced non-small cell lung cancer. Seminars in radiation oncology, 1999, Volume: 9, Issue:2 Suppl 1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Esophagitis; Female; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Paclitaxel; Prospective Studies; Radiotherapy; Survival Analysis	1999
Concurrent conventionally factionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma. British journal of cancer, 1999, Volume: 80, Issue:11 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Asthenia; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Docetaxel; Dose Fractionation, Radiation; Esophagitis; Female; Humans; Lung Neoplasms; Lymphopenia; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Radiotherapy; Survival Analysis; Taxoids	1999
Paclitaxel, cisplatin, and concurrent radiation for esophageal cancer. Cancer investigation, 2001, Volume: 19, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Esophagitis; Female; Humans; Male; Middle Aged; Neutropenia; Paclitaxel; Survival Rate	2001
Sequential chemo- and radiochemotherapy with weekly paclitaxel (Taxol) and 3D-conformal radiotherapy of stage III inoperable non-small cell lung cancer. Results of a dose escalation study. Lung cancer (Amsterdam, Netherlands), 2001, Volume: 32, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cohort Studies; Combined Modality Therapy; Disease-Free Survival; Drug Hypersensitivity; Esophagitis; Humans; Leukopenia; Life Tables; Lung Neoplasms; Maximum Tolerated Dose; Nausea; Neoplasm Staging; Paclitaxel; Prospective Studies; Radiation Injuries; Radiation Pneumonitis; Radiotherapy, Conformal; Remission Induction; Survival Analysis; Survival Rate; Treatment Outcome; Vomiting	2001
Phase II: trial of twice weekly amifostine in patients with non-small cell lung cancer treated with chemoradiotherapy. Seminars in radiation oncology, 2002, Volume: 12, Issue:1 Suppl 1 Topics: Acute Disease; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drug Administration Schedule; Esophagitis; Esophagus; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Radiation Injuries; Radiation-Protective Agents; Radiation-Sensitizing Agents; Survival Rate	2002

Other Studies

12 other study(ies) available for paclitaxel and Esophagitis

Article	Year
[Patient with Recurrent Breast Cancer Who Developed Radiation Esophagitis with Severe Esophageal Stenosis after Combined Bevacizumab and Paclitaxel Therapy-A Case Report]. Gan to kagaku ryoho. Cancer & chemotherapy, 2020, Volume: 47, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Esophageal Stenosis; Esophagitis; Female; Humans; Mastectomy; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Patients; Positron Emission Tomography Computed Tomography; Radiation	2020
A highly flexible paclitaxel-loaded poly(ε-caprolactone) electrospun fibrous-membrane-covered stent for benign cardia stricture. Acta biomaterialia, 2013, Volume: 9, Issue:9 Topics: Animals; Delayed-Action Preparations; Diffusion; Dogs; Drug-Eluting Stents; Elastic Modulus; Electrochemistry; Equipment Design; Equipment Failure Analysis; Esophageal Stenosis; Esophagitis; Female; Male; Materials Testing; Membranes, Artificial; Nanofibers; Paclitaxel; Polyesters; Rotation; Surface Properties; Treatment Outcome	2013
Efficacy and Tolerability of Palliative Split-Course Thoracic Chemoradiotherapy for Symptomatic Non-Small Cell Lung Cancer. American journal of clinical oncology, 2015, Volume: 38, Issue:6 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemoradiotherapy; Chest Pain; Cohort Studies; Cough; Dyspnea; Esophagitis; Etoposide; Female; Hemoptysis; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Palliative Care; Pemetrexed; Radiation Injuries; Radiation Pneumonitis; Retrospective Studies; Treatment Outcome	2015
[Value of postoperative radiochemotherapy for thoracic esophageal squamous cell carcinoma with lymph node metastasis]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2014, Volume: 36, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Esophagitis; Female; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Irradiation; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neutropenia; Paclitaxel; Particle Accelerators; Postoperative Period; Retrospective Studies; Survival Rate	2014
Predictors of acute esophagitis in lung cancer patients treated with concurrent three-dimensional conformal radiotherapy and chemotherapy. International journal of radiation oncology, biology, physics, 2009, Mar-01, Volume: 73, Issue:3 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Esophagitis; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Prospective Studies; Radiotherapy Dosage; Radiotherapy, Conformal; ROC Curve; Small Cell Lung Carcinoma; Tumor Burden; Vinblastine; Vinorelbine	2009
Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy. International journal of radiation oncology, biology, physics, 2012, Jan-01, Volume: 82, Issue:1 Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Adenoid Cystic; Carcinoma, Mucoepidermoid; Chemoradiotherapy; Dermatitis; Disease-Free Survival; Esophagitis; Female; Humans; Male; Middle Aged; Mucositis; Paclitaxel; Prognosis; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Radiotherapy, Intensity-Modulated; Retrospective Studies; Salivary Gland Neoplasms; Xerostomia	2012
Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancer. Cancer, 2011, Jul-01, Volume: 117, Issue:13 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Esophagitis; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Pneumonia; Proton Therapy; Protons; Radiotherapy Dosage; Radiotherapy, Conformal	2011
[Cytolytic hepatitis and esomeprazole during chemotherapy]. Presse medicale (Paris, France : 1983), 2005, Oct-08, Volume: 34, Issue:17 Topics: Adult; Anti-Ulcer Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemical and Drug Induced Liver Injury; Esomeprazole; Esophagitis; Female; Humans; Paclitaxel; Trastuzumab	2005
[Initial outcome of induction chemotherapy with weekly paclitaxel followed by three-dimensional conformal radiotherapy and concurrent weekly paclitaxel for stage III non-small cell lung cancer]. Ai zheng = Aizheng = Chinese journal of cancer, 2006, Volume: 25, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drug Administration Schedule; Esophagitis; Female; Follow-Up Studies; Humans; Lung Neoplasms; Lymphopenia; Male; Middle Aged; Paclitaxel; Radiotherapy, Conformal; Remission Induction; Survival Rate	2006
[Concurrent chemoradiation with paclitaxel and platinum for locally advanced esophageal cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2007, Volume: 29, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Esophagitis; Female; Follow-Up Studies; Humans; Leukopenia; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Particle Accelerators; Radiotherapy Dosage; Radiotherapy, High-Energy; Remission Induction; Survival Rate; Thrombocytopenia	2007
Paclitaxel and simultaneous radiation in the treatment of stage IIIA/B non-small cell lung cancer. Seminars in oncology, 1996, Volume: 23, Issue:6 Suppl 16 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drug Administration Schedule; Drug Tolerance; Esophagitis; Female; Humans; Leukopenia; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Pneumocystis Infections; Radiotherapy Dosage; Treatment Outcome	1996
Dosimetric predictors of radiation esophagitis in patients treated for non-small-cell lung cancer with carboplatin/paclitaxel/radiotherapy. International journal of radiation oncology, biology, physics, 2001, Oct-01, Volume: 51, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drug Administration Schedule; Esophagitis; Esophagoscopy; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Radiation Injuries; Radiotherapy Dosage; Radiotherapy, Conformal	2001